Abstract:Macroautophagy (hereafter referred to as autophagy) is a highly conserved lysosome-dependent degradation pathway in eukaryotic cells. Autophagy helps maintain cell homeostasis by eliminating unwanted cellular materials, including protein aggregates, damaged organelles and invading pathogens. Dysfunction of autophagy has been linked to a variety of human diseases, such as cancers, metabolic diseases and neurodegenerative diseases. As a sequential cellular process, autophagy is typically divided into several major steps, including autophagy initiation, membrane nucleation, phagophore expansion, autophagosome formation and autophagosome-lysosome fusion. These distinct autophagy steps are spatiotemporally controlled by a great number of autophagy-related proteins. Among these proteins, WIPI-family proteins, comprised with four members, have been demonstrated to play an important role in phagophore expansion. Mammalian WIPI1 and WIPI2 are highly related to yeast Atg18 while mammalian WIPI3 and WIPI4 are highly close to yeast Atg21. Of note, WIPI2 but not WIPI1 is essential for autophagy, and WIPI3 and WIPI4 are each only partially necessary for autophagy. During canonical autophagy, WIPI2 has been demonstrated to regulate phagophore expansion through several different mechanisms. On the phagophore, PI3P, produced by activated VPS34 complex, and RAB11A mediate the recruitment of WIPI2, which then recruits ATG16L1-ATG5-ATG12 complex by interacting with ATG16L1, resulting in the lipidation of ATG8-family proteins and the expansion of phagophore. Recently, WIPI2 is also shown to promote phagophore expansion by mediating the membrane contact between phagophore and endoplasmic reticulum through interacting with endoplasmic reticulum-localized ULK1 complex. In addition to nutrient starvation-induced canonical autophagy, WIPI2 is required for viral infection-induced non-canonical autophagy, which depends on the activation of cGAS-STING pathway. Interestingly, STING-induced autophagy does not require the upstream autophagic machinery, such as ULK1 complex and VPS34 complex. Stimulated by cytoplasmic DNA, activated cGAS synthesizes cGAMP, which binds to endoplasmic reticulum-localized STING to initiate its intracellular trafficking, leading to STING vesicle formation. By providing membrane sources, STING vesicles act as the primary sites for autophagosome formation. Through a direct interaction, STING brings WIPI2 to STING vesicles to mediate the subsequent recruitment of ATG16L1-ATG5-ATG12 complex, bypassing the upstream autophagic machinery. In response to different cellular or extracellular cues, a variety of WIPI2-based regulation mechanisms are adopted by the cell to tightly control autophagy. Under nutrient-rich conditions, activated mTORC1 phosphorylates WIPI2 to enhance its binding to E3 ubiquitin ligase HUWE1, leading to the proteasomal degradation of WIPI2 and the suppression of autophagy. Upon mitosis induction, activated E3 ubiquitin ligase CRL4 interacts with WIPI2 to promote its ubiquitination and proteasome-dependent degradation, resulting in autophagy inhibition. During bacterial infection, activated TBK1 promotes the recruitment of WIPI2-localized phagophores to bacteria for the initiation of xenophagy and the clearance of bacteria. It is worth noting that a mutation of WIPI2, decreasing its autophagic function, is associated with global developmental abnormalities in humans. In this paper, we aim to review the emerging roles of WIPI2 in the regulation of canonical and non-canonical autophagy.

The ATG5-binding and coiled coil domains of ATG16L1 maintain autophagy and tissue homeostasis in mice independently of the WD domain required for LC3-associated phagocytosis

Emerging roles of WIPI2 in canonical and non-canonical autophagy

Missing WD40 Repeats in ATG16L1 Delays Canonical Autophagy and Inhibits Noncanonical Autophagy

ZDHHC7-mediated S-palmitoylation of ATG16L1 facilitates LC3 lipidation and autophagosome formation

ATG16L1 is equipped with two distinct WIPI2-binding sites to drive autophagy

The role of ATG16L2 in autophagy and disease

Distinct functions of ATG16L1 isoforms in membrane binding and LC3B lipidation in autophagy-related processes

Mechanistic insights into the distinct functions of ATG16L1 in canonical autophagy and selective autophagy

Redundancy of human ATG4 protease isoforms in autophagy and LC3/GABARAP processing revealed in cells

Atg1-mediated Atg11 Phosphorylation is Required for Selective Autophagy by Regulating Its Association with Receptor Proteins.

Deacetylation of ATG7 drives the induction of macroautophagy and LC3-associated microautophagy

LUBAC and OTULIN regulate autophagy initiation and maturation by mediating the linear ubiquitination and the stabilization of ATG13

Roles Of The Lipid-Binding Motifs Of Atg18 And Atg21 In The Cytoplasm To Vacuole Targeting Pathway And Autophagy

ATG16L1 adopts a dual–binding site mode to interact with WIPI2b in autophagy

Regulation of ATG4B Stability by RNF5 Limits Basal Levels of Autophagy and Influences Susceptibility to Bacterial Infection.

The WD Domain of Atg16l1 Crucial for LC3-Associated Phagocytosis Is Not Required for Preserving Skin Barrier Function in Mice

ATG16L1 functions in cell homeostasis beyond autophagy

Distinct Tissue-Specific Roles for the Disease-Associated Autophagy Genes ATG16L2 and ATG16L1

Deletion of the WD40 domain of ATG16L1 exacerbates acute pancreatitis, abolishes LAP-like non-canonical autophagy and slows trypsin degradation

Suppression of autophagy during mitosis via CUL4-RING ubiquitin ligases-mediated WIPI2 polyubiquitination and proteasomal degradation

WIPI2 positively regulates mitophagy by promoting mitochondrial recruitment of VCP